Cannabis Science, Inc. (OTCBB: CBIS) a pioneering US biotech company developing pharmaceutical cannabis products, is very pleased to report that two former US Attorneys, and the former head of Seattle FBI, are in favor of Washington State Initiative 502 to legalize marijuana.
Anecdotal evidence beat out science in debate over the bill, which will ban 40 relatively unknown chemicals found in bath salts and fake pot, and make researching them difficult.
Four states, including Rhode Island, Washington, Vermont, and Colorado, are now petitioning the federal government to reclassify marijuana so it is no longer a Schedule 1 drug under the Controlled Substances Act.
Choosing the next President of the United States begins in Iowa in mere weeks. For the cannabis culture, 25 million people in the United States, there is only one option: Ron Paul.